SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-011951
Filing Date
2019-08-09
Accepted
2019-08-09 08:01:20
Documents
72
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 674493
2 ex31-1.htm EX-31.1 17621
3 ex31-2.htm EX-31.2 17927
4 ex32-1.htm EX-32.1 6266
5 ex32-2.htm EX-32.2 6460
  Complete submission text file 0001493152-19-011951.txt   3459780

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE vbiv-20190630.xml EX-101.INS 549794
7 XBRL SCHEMA FILE vbiv-20190630.xsd EX-101.SCH 64010
8 XBRL CALCULATION FILE vbiv-20190630_cal.xml EX-101.CAL 62897
9 XBRL DEFINITION FILE vbiv-20190630_def.xml EX-101.DEF 149449
10 XBRL LABEL FILE vbiv-20190630_lab.xml EX-101.LAB 342939
11 XBRL PRESENTATION FILE vbiv-20190630_pre.xml EX-101.PRE 237241
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37769 | Film No.: 191011348
SIC: 2834 Pharmaceutical Preparations